Insmed Incorporated

Equities

INSM

US4576693075

Market Closed - Nasdaq Other stock markets 01:30:00 10/03/2026 am IST			5-day change	1st Jan Change
143.13 ^USD	+2.14%		-2.18%	-17.76%

02/03	Insmed Incorporated Presents at TD Cowen 46th Annual Health Care Conference, Mar-02-2026 09:50 AM
24/02	Insmed Insider Sold Shares Worth $1,615,257, According to a Recent SEC Filing	MT

Transcript : Insmed Incorporated Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 03

Published on 01/13/2026 at 06:40 am IST

S&P Capital IQ

Presenter Speech
Jessica Fye (Analysts)

Great. Welcome, everyone. My name is Jess Fye. I'm a biotech analyst at JPMorgan, and we're delighted to be continuing the 44th Annual Healthcare Conference

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Insmed Incorporated

02/03	Insmed Incorporated Presents at TD Cowen 46th Annual Health Care Conference, Mar-02-2026 09:50 AM
24/02	Insmed Insider Sold Shares Worth $1,615,257, According to a Recent SEC Filing	MT
23/02	Mizuho Securities Cuts Insmed Price Target to $204 From $211, Maintains Outperform Rating	MT
23/02	Insmed Gets UK Marketing Authorization for Non-Cystic Fibrosis Bronchiectasis Treatment	MT
23/02	MHRA says licensed brensocatib as first drug for non-cystic fibrosis bronchiectasis in patients aged 12+	RE
20/02	Insmed Q4 Reinforces Confidence in Brinsupri Growth, RBC Says	MT
20/02	Insmed May Top Revenue Target for Bronchiectasis Drug Brinsupri, Morgan Stanley Says	MT
20/02	Morgan Stanley Lifts Price Target on Insmed to $166 From $162, Keeps Equalweight Rating	MT
20/02	US Equity Indexes Fall as Trump Signals Timeline on Iran Diplomacy	MT
19/02	Insmed Incorporated, Q4 2025 Earnings Call, Feb 19, 2026
19/02	Insmed Incorporated Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
19/02	The Market's Nerves Are Showing
19/02	Insmed reports fourth-quarter and full-year 2025 financial results and provides business update	RE
19/02	Insmed Q4 Loss Widens, Revenue Rises	MT
19/02	Earnings Flash (INSM) Insmed Incorporated Reports Q4 Revenue $263.8M, vs. FactSet Est of $237.8M	MT